World‑Renowned Dalhousie Bioethicist and Battery Pioneer Win Prestigious Killam Prize
By Andrew Riley and Caitlyn MacDonald,
Dal News
| 03. 15. 2022
Françoise Baylis, photo by XhenetaM,
CC BY-SA 4.0, via Wikimedia Commons
Two of Dalhousie’s leading researchers are being honoured with the $100,000 Killam Prize, winning two of the five prestigious awards granted annually by the Killam Trusts.
On Tuesday morning, the Canada Council for the Arts announced Françoise Baylis and Jeff Dahn as 2022 recipients of the honour. Offered to Canadian scholars who have distinguished themselves through sustained distinction and impact in their fields, the Killam Prize is considered the top national award of research excellence.
“It is a historic achievement for our university to have two Killam Prize winners in one year. Drs. Baylis and Dahn are known internationally for advancing knowledge in their fields – areas that promise to shape the way we live in the future,” says Deep Saini, Dalhousie’s president and vice-chancellor.
Drs. Baylis and Dahn are only the fifth and sixth Dalhousie faculty members to receive a Killam Prize since the awards were created in 1981. Biology’s Brian Hall (2005), Philosophy’s Susan Sherwin (2006), Chemistry's Axel Becke (2016), and Medicine's Ford Doolittle (2017)...
Related Articles
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Darren Incorvaia, Fierce Biotech | 05.28.2025
An international group of gene editing leaders has put out a call for a 10-year ban on heritable human genome editing (HHGE), extending a moratorium that was first proposed in the fallout of a Chinese researcher’s widely decried use of...
Last week, May 21–23, a broad range of experts gathered in Boston to discuss the future of powerful biotechnologies with the potential to change what it means to be human. The fourth in a series of international Summits on human genome editing, this event was organized by the Global Observatory for Genome Editing, which “seeks to expand the range of questions arising at the frontiers of emerging biotechnologies … and fosters international, interdisciplinary, and cross-sectoral dialogue.” Like previous Summits...
By Hannah Devlin, The Guardian | 05.23.2025
The sperm of a man carrying a rare cancer-causing mutation was used to conceive at least 67 children, 10 of whom have since been diagnosed with cancer, in a case that has highlighted concerns about the lack of internationally agreed...
